Precipio Inc (PRPO)

$25.71 -0.35 (-1.35%)
Market Cap 45.66M
Revenue (ttm) 18.53M
Net Income (ttm) -4.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -23.15%
Debt to Equity Ratio 0.01
Volume 3,600
Avg Vol 10,092
Day's Range N/A - N/A
Shares Out 1.75M
Stochastic %K 56%
Beta 1.12
Analysts Strong Buy
Price Target $40.00

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Hav...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 203 787 7888
Address:
4 Science Park, 3rd Floor, New Haven, United States
eddiel
eddiel Jan. 13 at 2:52 PM
$PRPO can we sniff at 30 today?
1 · Reply
diddy48
diddy48 Jan. 13 at 12:06 PM
$PRPO boom?
1 · Reply
Loren77
Loren77 Jan. 9 at 10:44 PM
$PRPO
0 · Reply
Bader0555
Bader0555 Jan. 9 at 4:31 PM
$PRPO This lion will soon awaken from his slumber
0 · Reply
tech_by_trade
tech_by_trade Jan. 9 at 3:48 AM
$PRPO wow, its been a while. Ilan hasn't pulled out the rug again yet. Must be waiting on a real good way to screw the bag holders.
2 · Reply
SinnagodKosher
SinnagodKosher Jan. 8 at 1:26 AM
$PRPO I agree! Up !!!
0 · Reply
eddiel
eddiel Jan. 7 at 8:52 PM
$PRPO up!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 3 at 3:10 AM
$PRPO RSI: 41.54, MACD: 0.1413 Vol: 0.73, MA20: 23.84, MA50: 22.65 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
1 · Reply
Belic
Belic Jan. 2 at 10:09 PM
$PRPO What's everyone predicting the share price is going to be at the end of this year? I'll go with $31.76
1 · Reply
imatisse
imatisse Jan. 1 at 6:35 AM
$PRPO $40 fast track Management knows
1 · Reply
Latest News on PRPO
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Dec 5, 2025, 10:00 AM EST - 5 weeks ago

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Dec 4, 2025, 8:00 AM EST - 5 weeks ago

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Precipio, Inc. (PRPO) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 17, 2025, 6:47 PM EST - 2 months ago

Precipio, Inc. (PRPO) Q3 2025 Earnings Call Prepared Remarks Transcript

Precipio Announces its Q3-2025 Financial Results

Nov 14, 2025, 4:30 PM EST - 2 months ago

Precipio Announces its Q3-2025 Financial Results

Precipio Announces Q3-2025 Shareholder Update Call

Nov 4, 2025, 5:00 PM EST - 2 months ago

Precipio Announces Q3-2025 Shareholder Update Call

Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:03 PM EDT - 5 months ago

Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Precipio Announces its Q2-2025 Financial Results

Aug 13, 2025, 5:00 PM EDT - 5 months ago

Precipio Announces its Q2-2025 Financial Results

Precipio Announces Q2-2025 Shareholder Update Call

Jul 31, 2025, 4:30 PM EDT - 5 months ago

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Jul 11, 2025, 4:30 PM EDT - 6 months ago

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

May 15, 2025, 6:02 PM EDT - 8 months ago

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

Precipio Announces its Q1-2025 Financial Results

May 14, 2025, 5:00 PM EDT - 8 months ago

Precipio Announces its Q1-2025 Financial Results

Precipio Announces Q1-2025 Shareholder Update Call

May 1, 2025, 5:00 PM EDT - 9 months ago

Precipio Announces Q1-2025 Shareholder Update Call

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 10:50 PM EDT - 10 months ago

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Mar 17, 2025, 5:00 PM EDT - 10 months ago

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Feb 25, 2025, 9:30 AM EST - 11 months ago

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Jan 16, 2025, 5:00 PM EST - 1 year ago

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Nov 18, 2024, 6:16 PM EST - 1 year ago

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Precipio Announces Q3-2024 Shareholder Update Call

Nov 6, 2024, 5:00 PM EST - 1 year ago

Precipio Announces Q3-2024 Shareholder Update Call

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Oct 8, 2024, 10:00 AM EDT - 1 year ago

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Precipio Announces Employee Stock Option Plan Repricing

Sep 6, 2024, 4:00 PM EDT - 1 year ago

Precipio Announces Employee Stock Option Plan Repricing

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Aug 19, 2024, 5:55 PM EDT - 1 year ago

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Precipio Announces Q2-2024 Shareholder Update Call

Aug 15, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Q2-2024 Shareholder Update Call

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Jun 13, 2024, 4:00 PM EDT - 1 year ago

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Jun 12, 2024, 4:00 PM EDT - 1 year ago

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Precipio Secures a short-term $500K Credit Facility

May 6, 2024, 5:00 PM EDT - 1 year ago

Precipio Secures a short-term $500K Credit Facility

Precipio Announces Year end 2023 Shareholder Update Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Year end 2023 Shareholder Update Call

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Feb 13, 2024, 10:00 AM EST - 2 years ago

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Feb 6, 2024, 10:00 AM EST - 2 years ago

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Jan 23, 2024, 10:00 AM EST - 2 years ago

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Jan 17, 2024, 10:30 AM EST - 2 years ago

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Precipio Announces Christina Valauri joins the Board of Directors

Jan 2, 2024, 9:00 AM EST - 2 years ago

Precipio Announces Christina Valauri joins the Board of Directors

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Dec 14, 2023, 4:30 PM EST - 2 years ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Nov 20, 2023, 6:38 PM EST - 2 years ago

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Precipio Announces Q3-2023 Shareholder Update Call

Nov 16, 2023, 5:00 PM EST - 2 years ago

Precipio Announces Q3-2023 Shareholder Update Call

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Oct 18, 2023, 9:00 AM EDT - 2 years ago

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Oct 3, 2023, 10:00 AM EDT - 2 years ago

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Precipio Continues to Sign New HemeScreen™ Customers

Sep 28, 2023, 9:00 AM EDT - 2 years ago

Precipio Continues to Sign New HemeScreen™ Customers

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Sep 25, 2023, 11:00 AM EDT - 2 years ago

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Sep 21, 2023, 9:00 AM EDT - 2 years ago

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Sep 13, 2023, 9:30 AM EDT - 2 years ago

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Aug 17, 2023, 6:32 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Precipio Announces Q2-2023 Shareholder Update Call

Aug 10, 2023, 5:00 PM EDT - 2 years ago

Precipio Announces Q2-2023 Shareholder Update Call

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Aug 8, 2023, 9:00 AM EDT - 2 years ago

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Aug 3, 2023, 9:00 AM EDT - 2 years ago

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Aug 1, 2023, 9:00 AM EDT - 2 years ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Jun 14, 2023, 9:49 AM EDT - 2 years ago

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Jun 13, 2023, 9:00 AM EDT - 2 years ago

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Jun 8, 2023, 8:30 AM EDT - 2 years ago

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

eddiel
eddiel Jan. 13 at 2:52 PM
$PRPO can we sniff at 30 today?
1 · Reply
diddy48
diddy48 Jan. 13 at 12:06 PM
$PRPO boom?
1 · Reply
Loren77
Loren77 Jan. 9 at 10:44 PM
$PRPO
0 · Reply
Bader0555
Bader0555 Jan. 9 at 4:31 PM
$PRPO This lion will soon awaken from his slumber
0 · Reply
tech_by_trade
tech_by_trade Jan. 9 at 3:48 AM
$PRPO wow, its been a while. Ilan hasn't pulled out the rug again yet. Must be waiting on a real good way to screw the bag holders.
2 · Reply
SinnagodKosher
SinnagodKosher Jan. 8 at 1:26 AM
$PRPO I agree! Up !!!
0 · Reply
eddiel
eddiel Jan. 7 at 8:52 PM
$PRPO up!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 3 at 3:10 AM
$PRPO RSI: 41.54, MACD: 0.1413 Vol: 0.73, MA20: 23.84, MA50: 22.65 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
1 · Reply
Belic
Belic Jan. 2 at 10:09 PM
$PRPO What's everyone predicting the share price is going to be at the end of this year? I'll go with $31.76
1 · Reply
imatisse
imatisse Jan. 1 at 6:35 AM
$PRPO $40 fast track Management knows
1 · Reply
diddy48
diddy48 Dec. 31 at 9:13 PM
$PRPO this stock is up 320% in 2025...but gets little attention....i see triple digits next year.....happy and healthy new year to everyone!
0 · Reply
imatisse
imatisse Dec. 30 at 6:30 PM
$PRPO • operational restructuring • improved cash management • strengthened financial discipline • improved operating leverage • improvement in pathology segment
0 · Reply
Loren77
Loren77 Dec. 30 at 2:41 PM
$PRPO the company has granted an aggregate of 70,000 performance-based stock options to its named executive officers and other senior management. These stock options will vest only if the company’s common stock achieves a 10-day volume-weighted average price above ---> $40 <--- per share, with no time-based vesting condition
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 30 at 3:26 AM
$PRPO
0 · Reply
Newbie3611
Newbie3611 Dec. 30 at 2:52 AM
$PRPO This interview was recently posted. https://www.linkedin.com/posts/precipio-diagnostics_as-part-of-our-officialdealflow-discovery-activity-7411593393769762816-YdMR
0 · Reply
JohnTrack
JohnTrack Dec. 29 at 10:28 PM
$PRPO headline hit, go read!! https://www.rapidticker.com/news/prpo-sec-filing-7c23b5
1 · Reply
Bader0555
Bader0555 Dec. 23 at 7:40 PM
If you couldn't buy $AFJK, don't miss the opportunity to buy $PRPO
0 · Reply
imatisse
imatisse Dec. 22 at 3:15 PM
$PRPO Catalysts: continued quarterly growth, expansion of international sales/distribution, additional product acceptance (molecular/pathology services), more efficient capital management. Positive investor sentiment with continued profitable quarters. … 👁️…All Within Reach !
0 · Reply
imatisse
imatisse Dec. 19 at 3:01 PM
$PRPO
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 17 at 7:02 PM
communicating with old P tickets old grid $PYX $PRPO * and among multiple more
0 · Reply
Loren77
Loren77 Dec. 17 at 3:23 PM
$PRPO 24$ Is a fortress. Breakout soon
0 · Reply
imatisse
imatisse Dec. 16 at 4:01 PM
$PRPO STRONG Under - Valuation versus peers (- Biodesix, Burning Rock, Natera) !!!
0 · Reply